EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru

Luis Jaramillo-Valverde, Marlon Yuri Garcia-Paitan, Dolly Landeo, Saul J Santivañez, Ramon Cacacabelos

Frontiers in Bioscience-Scholar · 2025

DOI: 10.31083/fbs40566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Scholar, 2025. Verfasst von Luis Jaramillo-Valverde und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Universidad Continental, 12001 Huancayo, Peru. Hauptthemen laut MEDLINE: Albendazole, Echinococcosis, Genetic Predisposition to Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Continental under the institutional funding framework established by Resolution.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hydatidosis, caused by Echinococcus granulosus, is a neglected zoonotic disease with significant public health implications in endemic regions, such as in Cusco, Peru. Genetic factors influencing susceptibility to infection and responses to albendazole, the primary treatment, remain unclear. Thus, this study aimed to investigates genetic polymorphisms associated with hydatidosis susceptibility and albendazole metabolism in the Cusco region.

Methods

Hence, a cross-sectional study was conducted using 20 individuals from endemic areas. Peripheral blood samples were collected for genomic DNA extraction, followed by single-nucleotide polymorphism (SNP) genotyping using the Illumina Global Screening Array. Polymorphisms in genes related to immunity (interleukin 10 (IL10), interleukin 17A (IL17A), vitamin D receptor (VDR), interferon gamma (IFNG), forkhead box P3 (FOXP3), interleukin 4 (IL4), tumor necrosis factor (TNF), toll-like receptor 4 (TLR4), cytotoxic T-lymphocyte antigen 4 (CTLA4), mannose-binding lectin 2 (MBL2), interleukin 12B (IL12B), and transforming growth factor-beta 1 (TGFB1)) and drug metabolism genes (cytochrome P450 family 3 subfamily A member 4 (CYP3A4), cytochrome P450 family 2 subfamily B member 6 (CYP2B6), cytochrome P450 family 1 subfamily A member 2 (CYP1A2), ATP-binding cassette subfamily B member 1 (ABCB1), solute carrier organic anion transporter family member 1B1 (SLCO1B1), and cytochrome P450 family 2 subfamily E member 1 (CYP2E1)) were analyzed.

Results

High-frequency alleles were identified in six SNPs associated with susceptibility to Echinococcus granulosus: IL10 rs1800896 (77.5%), IL17A rs2275913 (97.5%), IFNG rs2779249 (92.5%), FOXP3 rs11568821 (97.5%), TGFB1 rs1800469 (80.0%), and VDR rs2228570 (87.5%). Likewise, elevated allele frequencies were observed for two SNPs potentially involved in albendazole metabolism: CYP3A4 rs2740574 (87.5%) and CYP2B6 rs2266780 (97.5%). A comparative analysis with other populations revealed significant differences in SNP frequencies in the Cusco population, both in SNPs related to susceptibility (IL17A rs2275913, VDR rs2228570, and TGFB1 rs1800469; p < 0.001) and pharmacogenetic-related SNPs (CYP2B6 rs2266782, SLCO1B1 rs4149056, and CYP2E1 rs8330; p < 0.05), suggesting the existence of unique local genetic patterns.

Conclusion

These findings underscore the importance of pharmacogenetic screening to optimize albendazole therapy and support precision medical approaches for hydatidosis management in endemic regions. Further studies with larger cohorts are required to confirm these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleEchinococcosisGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotidePeruMaleFemaleAdultCross-Sectional StudiesMiddle AgedEchinococcus granulosusYoung AdultPharmacogeneticsAnimals

Stichwörter der Autor:innen

Echinococcus granulosusSNPsalbendazolegenetic susceptibilityhydatidosispharmacogenetics

Substanzen

Albendazole

Autor:innen und Institutionen

  • School of Medicine, Universidad Continental, 12001 Huancayo, Peru.
  • EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, 15165 Bergondo, Corunna, Spain.

Förderung

  • Universidad Continental under the institutional funding framework established by Resolution

Zitieren

APA

Jaramillo-Valverde, L., Garcia-Paitan, M. Y., Landeo, D., Santivañez, S. J., & Cacacabelos, R. (2025). Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/fbs40566

Vancouver

Jaramillo-Valverde L, Garcia-Paitan MY, Landeo D, Santivañez SJ, Cacacabelos R. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. Frontiers in Bioscience-Scholar. 2025. doi:10.31083/fbs40566

BibTeX
@article{JaramilloValverde2025,
  author = {Jaramillo-Valverde, Luis and Garcia-Paitan, Marlon Yuri and Landeo, Dolly and Santivañez, Saul J and Cacacabelos, Ramon},
  title = {Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru},
  journal = {Frontiers in Bioscience-Scholar},
  year = {2025},
  doi = {10.31083/fbs40566}
}
Kostenlos starten →